1205 related articles for article (PubMed ID: 26762955)
41. Is the age of genetic surgery finally upon us?
Kmiec EB
Surg Oncol; 2015 Jun; 24(2):95-9. PubMed ID: 25936245
[TBL] [Abstract][Full Text] [Related]
42. Harnessing CRISPR-Cas systems for bacterial genome editing.
Selle K; Barrangou R
Trends Microbiol; 2015 Apr; 23(4):225-32. PubMed ID: 25698413
[TBL] [Abstract][Full Text] [Related]
43. Extending CRISPR-Cas9 Technology from Genome Editing to Transcriptional Engineering in the Genus Clostridium.
Bruder MR; Pyne ME; Moo-Young M; Chung DA; Chou CP
Appl Environ Microbiol; 2016 Oct; 82(20):6109-6119. PubMed ID: 27496775
[TBL] [Abstract][Full Text] [Related]
44. Therapeutic editing of hepatocyte genome in vivo.
Ruiz de Galarreta M; Lujambio A
J Hepatol; 2017 Oct; 67(4):818-828. PubMed ID: 28527665
[TBL] [Abstract][Full Text] [Related]
45. Therapeutic Genome Editing and its Potential Enhancement through CRISPR Guide RNA and Cas9 Modifications.
Batzir NA; Tovin A; Hendel A
Pediatr Endocrinol Rev; 2017 Jun; 14(4):353-363. PubMed ID: 28613045
[TBL] [Abstract][Full Text] [Related]
46. Rapid Control of Genome Editing in Human Cells by Chemical-Inducible CRISPR-Cas Systems.
Liu KI; Ramli MNB; Sutrisnoh NB; Tan MH
Methods Mol Biol; 2018; 1772():267-288. PubMed ID: 29754234
[TBL] [Abstract][Full Text] [Related]
47. The genome editing revolution: A CRISPR-Cas TALE off-target story.
Stella S; Montoya G
Bioessays; 2016 Jul; 38 Suppl 1():S4-S13. PubMed ID: 27417121
[TBL] [Abstract][Full Text] [Related]
48. Progress of application and off-target effects of CRISPR/Cas9.
Zheng W; Gu F
Yi Chuan; 2015 Oct; 37(10):1003-10. PubMed ID: 26496752
[TBL] [Abstract][Full Text] [Related]
49. CRISPR-Cas9: A revolution in genome editing in rheumatic diseases.
Duroux-Richard I; Giovannangeli C; Apparailly F
Joint Bone Spine; 2017 Jan; 84(1):1-4. PubMed ID: 27825565
[No Abstract] [Full Text] [Related]
50. The era of editing plant genomes using CRISPR/Cas: A critical appraisal.
Bhat MA; Bhat MA; Kumar V; Wani IA; Bashir H; Shah AA; Rahman S; Jan AT
J Biotechnol; 2020 Dec; 324():34-60. PubMed ID: 32980369
[TBL] [Abstract][Full Text] [Related]
51. Evolution in crop improvement approaches and future prospects of molecular markers to CRISPR/Cas9 system.
Dheer P; Rautela I; Sharma V; Dhiman M; Sharma A; Sharma N; Sharma MD
Gene; 2020 Aug; 753():144795. PubMed ID: 32450202
[TBL] [Abstract][Full Text] [Related]
52. CRISPR/Cas9 and TALEN-mediated knock-in approaches in zebrafish.
Auer TO; Del Bene F
Methods; 2014 Sep; 69(2):142-50. PubMed ID: 24704174
[TBL] [Abstract][Full Text] [Related]
53. Simple knockout by electroporation of engineered endonucleases into intact rat embryos.
Kaneko T; Sakuma T; Yamamoto T; Mashimo T
Sci Rep; 2014 Oct; 4():6382. PubMed ID: 25269785
[TBL] [Abstract][Full Text] [Related]
54. Selection and Validation of Spacer Sequences for CRISPR-Cas9 Genome Editing and Transcription Regulation in Bacteria.
Grenier F; Lucier JF; Rodrigue S
Methods Mol Biol; 2015; 1334():233-44. PubMed ID: 26404154
[TBL] [Abstract][Full Text] [Related]
55. [Advances in genetic modification technologies].
Zhang B; Sun Q; Li H
Sheng Wu Gong Cheng Xue Bao; 2015 Aug; 31(8):1162-74. PubMed ID: 26762038
[TBL] [Abstract][Full Text] [Related]
56. Concerns regarding 'off-target' activity of genome editing endonucleases.
Kadam US; Shelake RM; Chavhan RL; Suprasanna P
Plant Physiol Biochem; 2018 Oct; 131():22-30. PubMed ID: 29653762
[TBL] [Abstract][Full Text] [Related]
57. A Single-Molecule View of Genome Editing Proteins: Biophysical Mechanisms for TALEs and CRISPR/Cas9.
Cuculis L; Schroeder CM
Annu Rev Chem Biomol Eng; 2017 Jun; 8():577-597. PubMed ID: 28489428
[TBL] [Abstract][Full Text] [Related]
58. Advances in therapeutic CRISPR/Cas9 genome editing.
Savić N; Schwank G
Transl Res; 2016 Feb; 168():15-21. PubMed ID: 26470680
[TBL] [Abstract][Full Text] [Related]
59. Nuclease-mediated genome editing: At the front-line of functional genomics technology.
Sakuma T; Woltjen K
Dev Growth Differ; 2014 Jan; 56(1):2-13. PubMed ID: 24387662
[TBL] [Abstract][Full Text] [Related]
60. CRISPR/Cas9 Platforms for Genome Editing in Plants: Developments and Applications.
Ma X; Zhu Q; Chen Y; Liu YG
Mol Plant; 2016 Jul; 9(7):961-74. PubMed ID: 27108381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]